{"id":"succinylated-gelatin-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Hyperamylasemia"},{"rate":null,"effect":"Coagulopathy"},{"rate":null,"effect":"Acute kidney injury"}]},"_chembl":{"chemblId":"CHEMBL2108518","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Succinylated gelatin is a modified gelatin derivative that functions as a colloid-based volume replacement agent. When administered intravenously, it increases plasma oncotic pressure, drawing fluid into the intravascular space and expanding circulating blood volume. This helps restore hemodynamic stability and tissue perfusion in hypovolemic states.","oneSentence":"Succinylated gelatin acts as a plasma volume expander by increasing colloid osmotic pressure to restore intravascular fluid volume.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:38:10.711Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypovolemia and shock requiring fluid resuscitation"},{"name":"Perioperative volume replacement during surgery"}]},"trialDetails":[{"nctId":"NCT06977763","phase":"NA","title":"Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Chia-tai Tianqing Pharmaceutical","startDate":"2025-07-01","conditions":"Acute Normovolemic Hemodilution","enrollment":104},{"nctId":"NCT06977750","phase":"NA","title":"Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Electrolyte Sodium Acetate Injection","status":"RECRUITING","sponsor":"Nanjing Chia-tai Tianqing Pharmaceutical","startDate":"2025-04-27","conditions":"Acute Normovolemic Hemodilution","enrollment":104},{"nctId":"NCT05117879","phase":"NA","title":"R0 Resection Rate Between CSP, cEMR and hEMR for 1-2 cm Colorectal SSLs","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2020-12-10","conditions":"Residual Disease","enrollment":120},{"nctId":"NCT05688020","phase":"PHASE4","title":"Tranexamic Acid During Upper GI Endoscopic Resection Procedures","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2023-02-01","conditions":"Gastric Polyp, Gastric Neoplasm, Duodenal Neoplasms","enrollment":200},{"nctId":"NCT00773110","phase":"PHASE2","title":"Study of Albumin to Reduce Inflammation Following Surgery","status":"TERMINATED","sponsor":"Imperial College London","startDate":"2008-12","conditions":"Systemic Inflammatory Response Syndrome, Cardiopulmonary Bypass","enrollment":232}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"succinylated gelatin injection","genericName":"succinylated gelatin injection","companyName":"Nanjing Chia-tai Tianqing Pharmaceutical","companyId":"nanjing-chia-tai-tianqing-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Succinylated gelatin acts as a plasma volume expander by increasing colloid osmotic pressure to restore intravascular fluid volume. Used for Hypovolemia and shock requiring fluid resuscitation, Perioperative volume replacement during surgery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}